News
Agenus (NASDAQ:AGEN) added ~21% in the premarket on Tuesday after the Massachusetts-based biotech announced a partnership ...
Ankit Aggarwal - Biotech Capital Markets In 2025: Discipline, Strategy, And A New Era Of Selectivity
Ankit Aggarwal is an Executive Director at J.P. Morgan in New York, where he leads capital markets and strategic advisory for ...
That curiosity led Patel to the C-Suite at cutting edge biotech company Rocket Pharmaceuticals ... a family from India found out their second child also had severe LAD-I. The family, living ...
Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
and Converge Biotech, a prominent healthcare company with a strong critical care and infectious disease focus in India, are pleased to announce a new strategic collaboration where the two ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
BENGALURU, Aug 18 (Reuters) - Shares of India's Concord Biotech (CONB.NS), opens new tab settled 27.2% higher at 942.8 rupees in their trading debut on Friday, valuing the biopharma company at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results